Cardiotoxicity of immunotherapy in lung cancer in light of new ESC guidelines
There has been rapid development of anticancer therapies involving monoclonal antibodies targeting immune checkpoints of the immune response. One of them is pembrolizumab (the anti-programmed death receptor 1 ligand - anti-PD-1) used in the treatment of malignant melanoma, non-small cell lung cancer...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
Śląski Uniwersytet Medyczny w Katowicach,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |